$BHVN 4 SEC Filings

Filed On	Filing
17 Sep 2026	Form 4: Gentile Kimberly, SVP, Clinical Operations Granted 1,000 Stock Options (Right to buy)
30 Apr 2026	Form 4: Mehta Kishan, Director Granted 68,693 Stock Options (Right to buy)
30 Apr 2026	Form 4: Bailey Gregory, Director Granted 68,693 Stock Options (Right to buy)
30 Apr 2026	Form 4: Heffernan Michael Thomas, Director Granted 68,693 Stock Options (Right to buy)
30 Apr 2026	Form 4: Antonijevic Irina, Director Granted 68,693 Stock Options (Right to buy)
30 Apr 2026	Form 4: Childs John W, Director Granted 68,693 Stock Options (Right to buy)
30 Apr 2026	Form 4: Hugin Robert J, Director Granted 68,693 Stock Options (Right to buy)
30 Apr 2026	Form 4: Gregory Julia P, Director Granted 68,693 Stock Options (Right to buy)
19 Mar 2026	Form 4: Mehta Kishan, Director Gave 17,342 shares as a gift · Acquired 17,342 shares (Gift)
03 Mar 2026	Form 4: Buten Matthew, Chief Financial Officer Granted 175,000 Stock Options (Right to buy)
03 Mar 2026	Form 4: Gentile Kimberly, SVP, Clinical Operations Granted 175,000 Stock Options (Right to buy)
03 Mar 2026	Form 4: Clark George C., VP, Chief Accounting Officer Granted 50,000 Stock Options (Right to buy)
03 Mar 2026	Form 4: Car Bruce, Chief Scientific Officer Granted 175,000 Stock Options (Right to buy)
03 Mar 2026	Form 4: Coric Vlad, Director Granted 550,000 Stock Options (Right to buy)
07 Jan 2026	Form 4: Buten Matthew, Chief Financial Officer Received 4,250 shares by exercise or conversion · Gave up 2,594 shares to cover exercise price or tax ($25.8K)
07 Jan 2026	Form 4: Coric Vlad, Director Received 14,250 shares by exercise or conversion · Gave up 7,430 shares to cover exercise price or tax ($73.8K)
07 Jan 2026	Form 4: Car Bruce, Chief Scientific Officer Received 4,750 shares by exercise or conversion · Gave up 2,381 shares to cover exercise price or tax ($23.6K)
07 Jan 2026	Form 4: Clark George C., VP, Chief Accounting Officer Received 2,500 shares by exercise or conversion · Gave up 1,117 shares to cover exercise price or tax ($11.1K)
07 Jan 2026	Form 4: Gentile Kimberly, SVP, Clinical Operations Received 3,750 shares by exercise or conversion · Gave up 1,956 shares to cover exercise price or tax ($19.4K)
18 Nov 2025	Form 4: Clark George C., VP, Chief Accounting Officer Bought 17,000 shares ($145K)

Comments